Cargando…
Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906642/ https://www.ncbi.nlm.nih.gov/pubmed/33617776 http://dx.doi.org/10.1016/S0140-6736(21)00357-3 |